Skip to main content

Moxatag FDA Approval History

FDA Approved: Yes (Discontinued) (First approved January 23, 2008)
Brand name: Moxatag
Generic name: amoxicillin
Dosage form: Extended Release Tablets
Company: Pragma
Treatment for: Tonsillitis/Pharyngitis

Marketing Status: Discontinued

Moxatag is a once-daily extended-release formulation of the penicillin antibiotic amoxicillin indicated for the treatment of adults and pediatric patients 12 years and older with pharyngitis and/or tonsillitis secondary to Streptococcus pyogenes (commonly referred to as strep throat).

Development timeline for Moxatag

Jan 24, 2008Approval FDA Approves MiddleBrook's Moxatag - Amoxicillin PULSYS - for Pharyngitis/Tonsillitis in Adolescents and Adults
May 22, 2007Advancis Pharmaceutical Announces FDA Acceptance of Amoxicillin PULSYS NDA
Mar 24, 2007Advancis Pharmaceutical Resubmits New Drug Application forOnce-Daily Amoxicillin PULSYS

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.